ASHLEY HOLT: Open Payments
NPI 1972815702 · ROCKVILLE, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$4,592 in 229 payments from 34 companies in 2025. Trend: 2023 $3,135 · 2024 $4,024 · 2025 $4,592
Food & beverage: $4,592
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 49 | $947 |
| PFIZER INC. | 21 | $374 |
| Novartis Pharmaceuticals Corporation | 26 | $308 |
| Eisai Inc. | 13 | $298 |
| Lundbeck LLC | 16 | $283 |
| Biogen, Inc. | 10 | $220 |
| Celgene Corporation | 16 | $208 |
| Lilly USA, LLC | 6 | $203 |
| EMD Serono, Inc. | 8 | $199 |
| UCB, Inc. | 6 | $166 |
Products named: QULIPTA, NURTEC ODT, KESIMPTA, Leqembi, VYEPTI, ZEPOSIA, AUSTEDO XR, UBRELVY.
Industry payments across MD — which companies pay providers there.
